508.6000 -17.95 (-3.41%)
NSE May 12, 2026 15:31 PM
Volume: 79,295
 

Axis Direct
We expect gross margins to be impacted due to an increase in revenue share from the non-regulated market going onwards, therefore recommend HOLD' with a target price of Rs 1,670/share (PE 20x for FY23EPS).
Solara Active Pharma Sciences Ltd. is trading above its 100 day SMA of 503.3
More from Solara Active Pharma Sciences Ltd.
Recommended